Delivery Order SPE2DB20D2104-SPE2DB24FT34Q
Award Date
3/29/24
Potential Completion Date
4/1/24
Potential Value
$9.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order for the pharmaceutical product Rexulti 1 mg tablet. The award, valued at $4,844.24, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support, a component of the U.S. Department of Defense. This delivery order falls under a larger indefinite delivery contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is a delivery order valued at $11,081.84 for the supply of the pharmaceutical product Rexulti 2 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has a period of performance through March 27, 2024. This delivery order is placed under a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the delivery of pharmaceutical products and medical supplies. The contract, a firm fixed price delivery order with a ceiling value of $3,961.21, is for the provision of Rexulti 0.5 mg tablets. The award has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corporation serves as the prime contractor on this...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,982.92 firm fixed-price delivery order is for the supply of Rexulti 2 mg tablets. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Rexulti 1 mg tablet, to the Defense Logistics Agency (DLA). The contract, valued at $4,866.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order that runs until February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,315.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rexulti 1 mg tablets and is a firm-fixed-price delivery order with an ultimate completion date of October 30, 2023. The contract is not designated as a set-aside and was awarded as part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $3,854.64 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the federal government. This order is for the drug Rexulti (0.25 mg tablet, 30s) and has a completion date of May 21, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,055.93 firm fixed-price delivery order is for the supply of Rexulti 1 mg tablets, a prescription medication. The contract has a completion date of February 21, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical and medical supply distributor. The $9,342.25 delivery order is for the supply of Rexulti 1 mg tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 and spanning through December 2025. This IDC enables DLA to efficiently...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $13,179.66 firm-fixed-price delivery order is for the supply of Rexulti 1 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...